+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 60Years
MALE
Healthy Volunteers
ID06742437

Study of HyperSperm, a New Sperm Capacitation Method, to Assess Safety and Effectiveness in Semen Samples In Vitro

Led by Fecundis Lab SL · Updated on 2026-02-27

300

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of HyperSperm, a new sperm capacitation method, in a prospective, multicenter in vitro study using 300 semen samples with different characteristics and abnormalities. This observational study aims to compare HyperSperm processing with standard sperm preparation methods over a 12-month period to better understand how this new technique may affect sperm function. Semen samples are grouped based on their sperm characteristics, including normal sperm parameters, abnormal morphology, reduced motility, low concentration, and frozen-thawed samples. Samples processed with HyperSperm will be compared to those treated with traditional preparation techniques. No interventions will be performed on participants themselves since this is a study on semen samples. Participants will provide semen samples collected by masturbation for laboratory analysis. Researchers will assess outcomes such as sperm hyperactivation, vitality, DNA fragmentation, motility, and survival at specific time points up to 20 hours after processing. The study will monitor these measures to evaluate the new capacitation methods impact on sperm quality and safety over the course of the study, which runs until June 2026.

CONDITIONS

Brief Title

Efficacy and Safety of a New Sperm Capacitation Method

Research Team

M

Matias Gomez Elias, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here